Clinical Trial Update: A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SKLB1028 Capsule in recurrence/refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• SKLB1028 Capsule

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN